People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dfmsim Inc | — | Other Technology | Pre-Seed | $1.4M | $5.8M | 2009 |
| Venquis Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $100K | $2.6M | 2021 |
Raj K Raheja at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Raj K Raheja on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen T McGrath | 1 | 2 |
| Amiel M Kornel | 1 | 2 |
| Robin M Jackman | 1 | 2 |
| Zhiyong K Wang | 1 | 1 |
| Raman K. Nurani | 1 | 1 |
| Nungavaram S. Viswanathan | 1 | 1 |
| James T. Healy | 1 | 1 |
| Matthias S. Frank | 1 | 1 |
| Anantha Sethuraman | 1 | 1 |
| Thomas T. Caulfield | 1 | 1 |
| Anantha R. Sethuraman | 1 | 1 |
| Thomas Caulfield | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.